News Archive

A recent study by the World Economic Forum showed a link between stress levels and daily intake of fibre and fermented foods.

Advocates for psychedelic therapy are pushing to get psilocybin and other psychedelics into the hands of active-duty military personnel to help treat PTSD sooner.

Clinical trials are now underway to investigate psychedelics’ effects on PLP, intractable depression, post-traumatic stress disorder, and opioid addiction.

Three leading psychedelic-research organizations are partnering to provide patients with virtual reality (VR) enhanced psychedelic therapy.

Johns Hopkins University researchers have received the first federal grant for psychedelic research in 50 years.

Trial participants will receive a microdose (10mg) of synthetic psilocybin, followed by a lager dose (25mg) one week later.

Professors in the Ontario Agricultural College’s Department of Plant Agriculture have received a Health Canada dealer’s licence allowing them to cultivate mushrooms that produce psilocybin and other compounds.

Alberta will become the first Canadian jurisdiction to regulate the use of psychedelic drugs for people in therapy, the province announced Wednesday.

Magic mushroom dispensary Chillum sells mushrooms containing Amanita muscaria, rather than the outlawed psilocybin

There’s no one-size-fits-all approach to treating depression and anxiety—but ketamine can be incredibly helpful for some.